Results of 3 studies focusing on circulating tumor cells (CTCs), conducted at The University of Texas MD Anderson Cancer Center, the University of Michigan Medical School, and the Lombardi Cancer Center at Georgetown University Medical Center, were presented on Thursday, December 13, at the 30th Annual San Antonio Breast Cancer Symposium (SABCS). All 3 studies employed CellTracks® technology and the CellSearch™ Circulating Tumor Cell (CTC) Kit developed by Immunicon Corporation (Huntingdon Valley, PA). The...